 |
 |
Search
- Page Path
-
- HOME
- Search
- Original Articles
- Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea
- Hui Xing Tan, Desmond Chun Hwee Teo, Dongyun Lee, Chungsoo Kim, Jing Wei Neo, Cynthia Sung, Haroun Chahed, Pei San Ang, Doreen Su Yin Tan, Rae Woong Park, Sreemanee Raaj Dorajoo
- Healthc Inform Res. 2022;28(2):112-122. Published online April 30, 2022
- Full text PubReader ePub PDF Supplementary Material
- Editorial Office
-
1618 Kyungheegung Achim Bldg 3, 34, Sajik-ro 8-gil, Jongno-gu, Seoul 03174, Korea
Tel: +82-2-733-7637, +82-2-734-7637 E-mail: hir@kosmi.org
Copyright © 2024 by Korean Society of Medical Informatics.
